Loading resource…

Herbert Tilg, MD; Salvatore Petta, MD; Norbert Stefan, MD; Giovanni Targher, MD
Metabolic dysfunction-associated steatotic liver disease (MASLD) encompasses a spectrum of liver conditions, from simple steatosis to steatohepatitis. It is a significant health concern, affecting a large portion of the adult population globally, particularly those with obesity and type 2 diabetes. The review details diagnostic criteria, associated risks, and treatment options, including lifestyle modifications and surgical interventions. It emphasizes the importance of recognizing MASLD due to its association with serious liver-related complications and other health issues.
No account needed